AKT1 and esophageal cancer: After our research, we proposed a new model, whereby the synergistic effect of combined treatment with cordycepin and cDDP is mainly achieved by upregulation of the AMPK and downregulation of the AKT signaling pathway in esophageal cancer cells (Fig. 9).